1.83
|
4.27e-85
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.71
|
5.46e-73
|
GO:0043170
|
macromolecule metabolic process
|
1.61
|
2.77e-72
|
GO:0044237
|
cellular metabolic process
|
1.57
|
1.12e-65
|
GO:0044238
|
primary metabolic process
|
1.49
|
6.76e-62
|
GO:0008152
|
metabolic process
|
1.96
|
6.88e-56
|
GO:0090304
|
nucleic acid metabolic process
|
1.98
|
5.73e-54
|
GO:0010467
|
gene expression
|
1.83
|
7.59e-52
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.99
|
1.53e-49
|
GO:0016070
|
RNA metabolic process
|
1.76
|
3.56e-49
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.73
|
1.65e-47
|
GO:0006807
|
nitrogen compound metabolic process
|
1.92
|
1.19e-44
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.92
|
2.18e-44
|
GO:0009059
|
macromolecule biosynthetic process
|
1.78
|
3.63e-44
|
GO:0044249
|
cellular biosynthetic process
|
1.71
|
7.07e-42
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.69
|
1.31e-41
|
GO:0031323
|
regulation of cellular metabolic process
|
1.75
|
1.77e-41
|
GO:0009058
|
biosynthetic process
|
1.86
|
3.09e-41
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.83
|
4.96e-40
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.62
|
1.70e-39
|
GO:0019222
|
regulation of metabolic process
|
1.80
|
3.06e-39
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.81
|
5.02e-39
|
GO:0010468
|
regulation of gene expression
|
1.67
|
5.56e-39
|
GO:0080090
|
regulation of primary metabolic process
|
1.78
|
1.00e-38
|
GO:0009889
|
regulation of biosynthetic process
|
1.84
|
9.65e-37
|
GO:0051252
|
regulation of RNA metabolic process
|
1.76
|
1.72e-35
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.75
|
2.79e-35
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.82
|
3.07e-34
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.83
|
1.24e-32
|
GO:0044267
|
cellular protein metabolic process
|
1.91
|
1.36e-29
|
GO:0006351
|
transcription, DNA-dependent
|
1.90
|
1.96e-29
|
GO:0032774
|
RNA biosynthetic process
|
1.64
|
4.10e-25
|
GO:0019538
|
protein metabolic process
|
1.19
|
1.40e-22
|
GO:0009987
|
cellular process
|
1.76
|
2.21e-20
|
GO:0043412
|
macromolecule modification
|
1.76
|
1.23e-19
|
GO:0006464
|
protein modification process
|
1.62
|
2.11e-18
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
2.18
|
2.86e-17
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.50
|
2.95e-17
|
GO:0071840
|
cellular component organization or biogenesis
|
2.19
|
3.20e-17
|
GO:0010629
|
negative regulation of gene expression
|
1.82
|
4.92e-17
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
2.12
|
6.00e-17
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
2.25
|
7.53e-17
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.95
|
7.99e-17
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.96
|
9.80e-17
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
2.23
|
1.17e-16
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.60
|
1.30e-16
|
GO:0048523
|
negative regulation of cellular process
|
1.47
|
2.34e-16
|
GO:0032502
|
developmental process
|
2.12
|
2.37e-16
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.80
|
2.63e-16
|
GO:0031325
|
positive regulation of cellular metabolic process
|
2.08
|
2.69e-16
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.76
|
6.38e-16
|
GO:0009893
|
positive regulation of metabolic process
|
1.59
|
6.67e-16
|
GO:0071842
|
cellular component organization at cellular level
|
2.13
|
6.96e-16
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
2.03
|
7.40e-16
|
GO:0009790
|
embryo development
|
2.13
|
1.07e-15
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.53
|
1.40e-15
|
GO:0048522
|
positive regulation of cellular process
|
1.87
|
2.39e-15
|
GO:0009892
|
negative regulation of metabolic process
|
1.49
|
2.51e-15
|
GO:0016043
|
cellular component organization
|
1.91
|
3.16e-15
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.49
|
4.18e-15
|
GO:0048518
|
positive regulation of biological process
|
2.67
|
4.69e-15
|
GO:0016568
|
chromatin modification
|
1.73
|
5.46e-15
|
GO:0006996
|
organelle organization
|
1.47
|
8.31e-15
|
GO:0007275
|
multicellular organismal development
|
2.29
|
1.63e-14
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
2.28
|
3.99e-14
|
GO:0043009
|
chordate embryonic development
|
1.93
|
4.99e-14
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.53
|
5.20e-14
|
GO:0048519
|
negative regulation of biological process
|
2.49
|
6.36e-14
|
GO:0006325
|
chromatin organization
|
2.22
|
1.07e-13
|
GO:0006396
|
RNA processing
|
1.87
|
2.69e-13
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
2.23
|
4.24e-13
|
GO:0051276
|
chromosome organization
|
1.47
|
5.50e-13
|
GO:0048856
|
anatomical structure development
|
1.94
|
6.96e-13
|
GO:0007049
|
cell cycle
|
1.84
|
9.05e-13
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.91
|
1.66e-12
|
GO:0010628
|
positive regulation of gene expression
|
1.87
|
3.46e-12
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.86
|
3.49e-12
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.94
|
5.77e-12
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
2.29
|
6.88e-12
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.92
|
9.49e-12
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.47
|
1.57e-11
|
GO:0048731
|
system development
|
1.56
|
3.95e-11
|
GO:0048513
|
organ development
|
1.65
|
4.32e-11
|
GO:0009653
|
anatomical structure morphogenesis
|
2.46
|
1.19e-09
|
GO:0006412
|
translation
|
1.78
|
1.42e-09
|
GO:0009888
|
tissue development
|
2.48
|
1.67e-09
|
GO:0008380
|
RNA splicing
|
1.93
|
2.20e-09
|
GO:0009887
|
organ morphogenesis
|
2.13
|
3.31e-09
|
GO:0048598
|
embryonic morphogenesis
|
2.00
|
1.37e-08
|
GO:0072358
|
cardiovascular system development
|
2.00
|
1.37e-08
|
GO:0072359
|
circulatory system development
|
2.27
|
1.64e-08
|
GO:0035295
|
tube development
|
2.22
|
2.02e-08
|
GO:0016071
|
mRNA metabolic process
|
2.90
|
2.47e-08
|
GO:0048705
|
skeletal system morphogenesis
|
2.01
|
2.50e-08
|
GO:0006259
|
DNA metabolic process
|
1.66
|
4.22e-08
|
GO:0050793
|
regulation of developmental process
|
2.33
|
5.40e-08
|
GO:0048568
|
embryonic organ development
|
2.33
|
6.42e-08
|
GO:0006397
|
mRNA processing
|
1.95
|
7.62e-08
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
2.33
|
1.11e-07
|
GO:0001501
|
skeletal system development
|
3.32
|
1.87e-07
|
GO:0018205
|
peptidyl-lysine modification
|
2.05
|
3.18e-07
|
GO:0032583
|
regulation of gene-specific transcription
|
2.05
|
3.63e-07
|
GO:0060429
|
epithelium development
|
2.27
|
4.27e-07
|
GO:0018193
|
peptidyl-amino acid modification
|
2.22
|
4.48e-07
|
GO:0001701
|
in utero embryonic development
|
2.57
|
4.74e-07
|
GO:0016569
|
covalent chromatin modification
|
2.26
|
6.10e-07
|
GO:0002009
|
morphogenesis of an epithelium
|
1.42
|
6.98e-07
|
GO:0048869
|
cellular developmental process
|
1.57
|
7.27e-07
|
GO:0007399
|
nervous system development
|
1.43
|
7.39e-07
|
GO:0030154
|
cell differentiation
|
2.56
|
8.31e-07
|
GO:0016570
|
histone modification
|
1.71
|
1.10e-06
|
GO:0045595
|
regulation of cell differentiation
|
2.11
|
1.39e-06
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
2.06
|
2.44e-06
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.82
|
2.92e-06
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
2.75
|
3.49e-06
|
GO:0060541
|
respiratory system development
|
1.59
|
4.58e-06
|
GO:0006796
|
phosphate metabolic process
|
1.59
|
5.34e-06
|
GO:0006793
|
phosphorus metabolic process
|
2.32
|
5.79e-06
|
GO:0034660
|
ncRNA metabolic process
|
2.18
|
7.39e-06
|
GO:0007507
|
heart development
|
2.01
|
7.44e-06
|
GO:0048729
|
tissue morphogenesis
|
2.98
|
1.51e-05
|
GO:0016331
|
morphogenesis of embryonic epithelium
|
1.81
|
1.62e-05
|
GO:0051094
|
positive regulation of developmental process
|
3.80
|
1.84e-05
|
GO:0060606
|
tube closure
|
2.11
|
1.85e-05
|
GO:0001568
|
blood vessel development
|
1.57
|
2.31e-05
|
GO:0044085
|
cellular component biogenesis
|
1.57
|
2.55e-05
|
GO:0042981
|
regulation of apoptosis
|
1.69
|
2.61e-05
|
GO:0006468
|
protein phosphorylation
|
1.61
|
2.74e-05
|
GO:2000026
|
regulation of multicellular organismal development
|
2.26
|
3.23e-05
|
GO:0043193
|
positive regulation of gene-specific transcription
|
2.38
|
3.59e-05
|
GO:0048562
|
embryonic organ morphogenesis
|
1.55
|
3.74e-05
|
GO:0010941
|
regulation of cell death
|
2.20
|
4.11e-05
|
GO:0048514
|
blood vessel morphogenesis
|
2.02
|
4.42e-05
|
GO:0001944
|
vasculature development
|
1.50
|
4.68e-05
|
GO:0009966
|
regulation of signal transduction
|
1.55
|
5.67e-05
|
GO:0043067
|
regulation of programmed cell death
|
3.70
|
7.10e-05
|
GO:0001843
|
neural tube closure
|
1.61
|
8.85e-05
|
GO:0016310
|
phosphorylation
|
1.80
|
8.91e-05
|
GO:0060548
|
negative regulation of cell death
|
1.73
|
1.09e-04
|
GO:0022402
|
cell cycle process
|
1.55
|
1.12e-04
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.57
|
1.13e-04
|
GO:0042127
|
regulation of cell proliferation
|
1.89
|
1.20e-04
|
GO:0045597
|
positive regulation of cell differentiation
|
2.49
|
1.21e-04
|
GO:0006260
|
DNA replication
|
3.05
|
1.29e-04
|
GO:0035148
|
tube formation
|
1.90
|
2.01e-04
|
GO:0007389
|
pattern specification process
|
2.20
|
2.08e-04
|
GO:0048732
|
gland development
|
3.51
|
2.11e-04
|
GO:0014020
|
primary neural tube formation
|
2.62
|
2.12e-04
|
GO:0030323
|
respiratory tube development
|
2.17
|
2.31e-04
|
GO:0035239
|
tube morphogenesis
|
1.80
|
2.58e-04
|
GO:0043066
|
negative regulation of apoptosis
|
1.93
|
2.64e-04
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
1.82
|
2.92e-04
|
GO:0022403
|
cell cycle phase
|
1.82
|
3.62e-04
|
GO:0044265
|
cellular macromolecule catabolic process
|
2.58
|
4.62e-04
|
GO:0030324
|
lung development
|
1.77
|
4.72e-04
|
GO:0043069
|
negative regulation of programmed cell death
|
1.39
|
4.92e-04
|
GO:0048583
|
regulation of response to stimulus
|
2.29
|
5.10e-04
|
GO:0010552
|
positive regulation of gene-specific transcription from RNA polymerase II promoter
|
1.85
|
5.52e-04
|
GO:0000278
|
mitotic cell cycle
|
3.00
|
5.55e-04
|
GO:0001838
|
embryonic epithelial tube formation
|
3.00
|
5.55e-04
|
GO:0072175
|
epithelial tube formation
|
2.85
|
6.19e-04
|
GO:2000027
|
regulation of organ morphogenesis
|
2.67
|
7.03e-04
|
GO:0021915
|
neural tube development
|
5.85
|
8.19e-04
|
GO:0018022
|
peptidyl-lysine methylation
|
1.90
|
9.00e-04
|
GO:0051301
|
cell division
|
3.57
|
1.24e-03
|
GO:0001889
|
liver development
|
3.10
|
1.44e-03
|
GO:0001841
|
neural tube formation
|
2.26
|
1.45e-03
|
GO:0060562
|
epithelial tube morphogenesis
|
1.92
|
1.50e-03
|
GO:0045596
|
negative regulation of cell differentiation
|
2.86
|
1.56e-03
|
GO:0040029
|
regulation of gene expression, epigenetic
|
2.22
|
1.65e-03
|
GO:0034470
|
ncRNA processing
|
3.50
|
1.77e-03
|
GO:0061008
|
hepaticobiliary system development
|
1.90
|
1.89e-03
|
GO:0070647
|
protein modification by small protein conjugation or removal
|
3.06
|
1.91e-03
|
GO:0018394
|
peptidyl-lysine acetylation
|
3.59
|
2.24e-03
|
GO:0060349
|
bone morphogenesis
|
1.46
|
2.72e-03
|
GO:0051246
|
regulation of protein metabolic process
|
1.13
|
3.29e-03
|
GO:0050794
|
regulation of cellular process
|
1.12
|
3.33e-03
|
GO:0065007
|
biological regulation
|
1.97
|
3.55e-03
|
GO:0003002
|
regionalization
|
2.57
|
4.18e-03
|
GO:0006399
|
tRNA metabolic process
|
1.73
|
4.97e-03
|
GO:0051247
|
positive regulation of protein metabolic process
|
1.83
|
5.20e-03
|
GO:0007420
|
brain development
|
1.12
|
5.73e-03
|
GO:0050789
|
regulation of biological process
|
2.97
|
5.96e-03
|
GO:0006475
|
internal protein amino acid acetylation
|
2.97
|
5.96e-03
|
GO:0018393
|
internal peptidyl-lysine acetylation
|
1.57
|
6.67e-03
|
GO:0033554
|
cellular response to stress
|
1.74
|
7.01e-03
|
GO:0032270
|
positive regulation of cellular protein metabolic process
|
2.17
|
7.63e-03
|
GO:0006730
|
one-carbon metabolic process
|
2.93
|
7.75e-03
|
GO:0006479
|
protein methylation
|
2.93
|
7.75e-03
|
GO:0008213
|
protein alkylation
|
2.65
|
7.99e-03
|
GO:0022612
|
gland morphogenesis
|
1.94
|
8.89e-03
|
GO:0061061
|
muscle structure development
|
2.82
|
9.11e-03
|
GO:0006473
|
protein acetylation
|
2.43
|
9.52e-03
|
GO:0032259
|
methylation
|
1.95
|
9.76e-03
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.99
|
9.93e-03
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
2.56
|
1.05e-02
|
GO:0043414
|
macromolecule methylation
|
2.12
|
1.12e-02
|
GO:0007346
|
regulation of mitotic cell cycle
|
2.59
|
1.23e-02
|
GO:0048706
|
embryonic skeletal system development
|
2.85
|
1.28e-02
|
GO:0048704
|
embryonic skeletal system morphogenesis
|
1.65
|
1.32e-02
|
GO:0009057
|
macromolecule catabolic process
|
1.81
|
1.35e-02
|
GO:0008283
|
cell proliferation
|
2.91
|
1.40e-02
|
GO:0016573
|
histone acetylation
|
1.36
|
1.41e-02
|
GO:0023051
|
regulation of signaling
|
1.48
|
1.42e-02
|
GO:0022607
|
cellular component assembly
|
2.16
|
1.55e-02
|
GO:0010553
|
negative regulation of gene-specific transcription from RNA polymerase II promoter
|
1.72
|
1.99e-02
|
GO:0051093
|
negative regulation of developmental process
|
2.19
|
2.00e-02
|
GO:0001655
|
urogenital system development
|
2.06
|
2.27e-02
|
GO:0009952
|
anterior/posterior pattern formation
|
1.67
|
2.34e-02
|
GO:0007417
|
central nervous system development
|
3.72
|
2.37e-02
|
GO:0045669
|
positive regulation of osteoblast differentiation
|
2.74
|
2.63e-02
|
GO:0050657
|
nucleic acid transport
|
2.74
|
2.63e-02
|
GO:0050658
|
RNA transport
|
2.74
|
2.63e-02
|
GO:0051236
|
establishment of RNA localization
|
2.02
|
2.75e-02
|
GO:0071843
|
cellular component biogenesis at cellular level
|
1.65
|
2.81e-02
|
GO:0051726
|
regulation of cell cycle
|
1.56
|
2.82e-02
|
GO:0046907
|
intracellular transport
|
2.35
|
2.84e-02
|
GO:0090092
|
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
|
1.92
|
2.99e-02
|
GO:0016567
|
protein ubiquitination
|
1.87
|
3.13e-02
|
GO:0032446
|
protein modification by small protein conjugation
|
1.82
|
3.18e-02
|
GO:0006281
|
DNA repair
|
1.81
|
3.53e-02
|
GO:0044257
|
cellular protein catabolic process
|
2.93
|
3.56e-02
|
GO:0016458
|
gene silencing
|
2.93
|
3.56e-02
|
GO:0060348
|
bone development
|
1.46
|
3.69e-02
|
GO:0048468
|
cell development
|
1.78
|
3.82e-02
|
GO:0030163
|
protein catabolic process
|
2.16
|
3.88e-02
|
GO:0042692
|
muscle cell differentiation
|
1.84
|
3.93e-02
|
GO:0006511
|
ubiquitin-dependent protein catabolic process
|
2.49
|
3.97e-02
|
GO:0030879
|
mammary gland development
|
2.82
|
4.18e-02
|
GO:0045667
|
regulation of osteoblast differentiation
|
2.03
|
4.20e-02
|
GO:0022613
|
ribonucleoprotein complex biogenesis
|
1.48
|
4.24e-02
|
GO:0048584
|
positive regulation of response to stimulus
|
1.81
|
4.37e-02
|
GO:0051603
|
proteolysis involved in cellular protein catabolic process
|
2.59
|
4.45e-02
|
GO:0060485
|
mesenchyme development
|
2.09
|
4.58e-02
|
GO:0043434
|
response to peptide hormone stimulus
|
1.98
|
4.61e-02
|
GO:0032582
|
negative regulation of gene-specific transcription
|
2.53
|
4.67e-02
|
GO:0015931
|
nucleobase, nucleoside, nucleotide and nucleic acid transport
|